Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the U.S. Food and Drug Administration (FDA), for the treatment of depression, specifically for individuals with TRD
Tulasi Healthcare, mental well-being platform, has announced the launch of its latest Deep Transcranial Magnetic Stimulation (dTMS) therapy service. This therapy aims to provide effective treatment for individuals facing treatment-resistant depression (TRD), helping them find renewed hope and relief from their symptoms.
Since its launch in July 2023, Tulasi Healthcare has successfully treated 4 patients with treatment-resistant depression. The emotional and mental-wellness platform aims to expand its reach and impact, with plans to treat 50 patients per month. Each dTMS session lasts approximately 20 to 30 minutes, and the total number of sessions may vary depending on the prescribed treatment protocol, lasting up to 4-6 weeks or up to 12 weeks in some cases.
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the U.S. Food and Drug Administration (FDA), for the treatment of depression, specifically for individuals with TRD. Treatment-resistant depression is a form of depression that does not respond adequately to standard treatments, such as antidepressant medications and psychotherapy.
dTMS therapy works by delivering repetitive magnetic pulses to target specific brain regions, such as the left dorsolateral prefrontal cortex, inducing neuroplastic changes that enhance neural circuit connectivity and mood regulation. This advanced form of transcranial magnetic stimulation (TMS) has shown promising results in treating treatment-resistant OCD and depression.
“We are excited to offer a transformative solution for individuals battling treatment-resistant depression, a challenge that has been daunting for many. With our non-invasive brain stimulation technique, approved by regulatory authorities, we are determined to provide patients with an effective path towards recovery. Our team of expert psychiatrists and clinical psychologists is committed to delivering compassionate care and personalised treatment plans, ensuring that each patient receives the support they need to overcome TRD and achieve lasting mental well-being. At Tulasi Healthcare, we believe that everyone deserves the chance to lead a productive and happy life, and our dTMS therapy service stands as a beacon of hope for those in need” said Dr Gorav Gupta, Co- Founder of Tulasi Healthcare and Emoneeds.
The response to dTMS may vary among individuals, with some experiencing improvements in depressive symptoms after just a few weeks of treatment, while for others, it may take longer to observe significant changes. The comprehensive approach of Tulasi Healthcare allows for the integration of dTMS with other treatment modalities, such as antidepressant medications or psychotherapy, tailored to meet the specific needs and treatment goals of each patient.